house · trading 2015-11-02 → 2024-11-21
*Notional-weighted price return on disclosed buys, marked to the latest close — open positions, per-share (share counts aren't disclosed, so this is price performance, not realized $ P&L).
| Date | Ticker | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2024-11-21 | SPY | SELL | $1K–$15K | $593.67 | $728.99 2026-06-26 | +3.6% rt |
| 2024-11-21 | SPY | BUY | $1K–$15K | $593.67 | $728.99 2026-06-26 | +22.8% |
| 2024-11-21 | ITB | SELL | $1K–$15K | — | — | — exit |
| 2024-10-04 | SPY | BUY | $1K–$15K | $572.98 | $728.99 2026-06-26 | +27.2% |
| 2024-07-24 | SP | BUY | $1K–$15K | — | — | — |
| 2024-07-24 | NTAP | SELL | $1K–$15K | $125.70 | $152.45 2026-06-26 | +121.2% rt |
| 2024-07-24 | NTAP | BUY | $1K–$15K | $125.70 | $152.45 2026-06-26 | +21.3% |
| 2024-07-22 | SP | BUY | $1K–$15K | — | — | — |
| 2024-03-20 | SP | SELL | $1K–$15K | — | — | — exit |
| 2024-03-20 | SP | BUY | $1K–$15K | — | — | — |
| 2024-03-20 | META | BUY | $1K–$15K | $505.52 | $550.25 2026-06-26 | +8.8% |
| 2024-03-01 | META | BUY | $1K–$15K | $502.30 | $550.25 2026-06-26 | +9.6% |
| 2023-12-06 | NTAP | SELL | $1K–$15K | $89.40 | $152.45 2026-06-26 | +29.7% rt |
| 2023-12-01 | NTAP | BUY | $1K–$15K | $91.28 | $152.45 2026-06-26 | +67.0% |
| 2023-07-07 | NTAP | BUY | $1K–$15K | $76.25 | $152.45 2026-06-26 | +99.9% |
| 2023-06-05 | TREA | SELL | $1K–$15K | — | — | — exit |
| 2023-06-05 | NTAP | SELL | $1K–$15K | $70.28 | $152.45 2026-06-26 | -7.7% rt |
| 2023-06-05 | NTAP | BUY | $50K–$50K | $70.28 | $152.45 2026-06-26 | +116.9% |
| 2023-06-05 | NTAP | BUY | $1K–$15K | $70.28 | $152.45 2026-06-26 | +116.9% |
| 2022-11-07 | SP | BUY | $1K–$15K | — | — | — |
| 2022-08-29 | SP | BUY | $1K–$15K | — | — | — |
| 2022-08-17 | SP | BUY | $1K–$15K | — | — | — |
| 2022-08-15 | SP | BUY | $1K–$15K | — | — | — |
| 2022-08-04 | SP | BUY | $1K–$15K | — | — | — |
| 2022-07-25 | NTAP | BUY | $1K–$15K | $69.17 | $152.45 2026-06-26 | +120.4% |
| 2022-07-19 | NTAP | BUY | $1K–$15K | $68.31 | $152.45 2026-06-26 | +123.2% |
| 2022-07-18 | NTAP | BUY | $1K–$15K | $65.57 | $152.45 2026-06-26 | +132.5% |
| 2022-07-18 | META | BUY | $1K–$15K | $167.23 | $550.25 2026-06-26 | +229.0% |
| 2022-06-06 | SP | BUY | $1K–$15K | — | — | — |
| 2021-11-09 | SP | SELL | $1K–$15K | — | — | — exit |
| 2021-11-09 | SP | BUY | $1K–$15K | — | — | — |
| 2021-11-08 | SP | SELL | $1K–$15K | — | — | — exit |
| 2021-11-08 | SP | BUY | $1K–$15K | — | — | — |
| 2021-10-26 | SP | BUY | $1K–$15K | — | — | — |
| 2021-10-26 | NTAP | SELL | $1K–$15K | $90.66 | $152.45 2026-06-26 | +5.5% rt |
| 2021-10-26 | NTAP | BUY | $1K–$15K | $90.66 | $152.45 2026-06-26 | +68.2% |
| 2021-10-25 | SP | BUY | $1K–$15K | — | — | — |
| 2021-10-25 | NTAP | BUY | $1K–$15K | $93.10 | $152.45 2026-06-26 | +63.8% |
| 2021-06-01 | SP | BUY | $1K–$15K | — | — | — |
| 2021-05-28 | SP | BUY | $1K–$15K | — | — | — |
| 2021-05-17 | SP | BUY | $1K–$15K | — | — | — |
| 2021-05-12 | SP | BUY | $1K–$15K | — | — | — |
| 2021-05-10 | SP | BUY | $1K–$15K | — | — | — |
| 2021-04-26 | SP | BUY | $1K–$15K | — | — | — |
| 2021-04-20 | SP | BUY | $1K–$15K | — | — | — |
| 2021-03-19 | NTAP | BUY | $1K–$15K | $70.16 | $152.45 2026-06-26 | +117.3% |
| 2021-02-16 | NTAP | BUY | $1K–$15K | $68.85 | $152.45 2026-06-26 | +121.4% |
| 2021-02-08 | GSK | BUY | $1K–$15K | $35.46 | $52.50 2026-06-26 | +48.0% |
| 2020-12-30 | META | BUY | $1K–$15K | $271.87 | $550.25 2026-06-26 | +102.4% |
| 2020-12-28 | NET | BUY | $1K–$15K | $77.50 | $237.24 2026-06-26 | +206.1% |
Return: buys are marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (how the stock moved after the sale, seller's perspective).
| Member | Shared tickers |
|---|---|
| Hon. Rohit Khanna | 5 · GSK, META, NTAP, SP, SPY |
| Hon. Mike Kelly | 4 · GSK, META, SP, SPY |
| JOHN BOOZMAN | 4 · GSK, META, NTAP, SPY |
| Hon. Rob Bresnahan | 3 · META, NET, SPY |
| Hon. Josh Gottheimer | 3 · META, NET, SPY |
| THOMAS R CARPER | 3 · GSK, NTAP, SPY |
| Hon. Kurt Schrader | 2 · GSK, SPY |
| Hon. Virginia Foxx | 2 · GSK, NAT |
| Hon. Kenny Marchant | 2 · GSK, SPY |
| Hon. James B. Renacci | 2 · GSK, SPY |
| Hon. K. Michael Conaway | 2 · GSK, SPY |
| Hon. Charles J. "Chuck" Fleischmann | 2 · GSK, SPY |